Market Overview:

According to IMARC Group's latest research publication, "Biomaterials Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2026-2034", The global biomaterials market size reached USD 138.3 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 315.2 Billion by 2034, exhibiting a growth rate (CAGR) of 9.29% during 2026-2034. 

This detailed analysis primarily encompasses industry size, business trends, market share, key growth factors, and regional forecasts. The report offers a comprehensive overview and integrates research findings, market assessments, and data from different sources. It also includes pivotal market dynamics like drivers and challenges, while also highlighting growth opportunities, financial insights, technological improvements, emerging trends, and innovations. Besides this, the report provides regional market evaluation, along with a competitive landscape analysis.

How 3D Printing Is Transforming the Biomaterials Market

• 3D printing enables patient-specific implant designs in orthopedics, dentistry, and oncological reconstruction, with Nanavati Max Super Specialty Hospital launching a dedicated medical 3D printing lab in Mumbai in February 2024 to facilitate such precision surgeries.
• Evonik introduced the world's first carbon-fiber-reinforced PEEK filament for long-term 3D-printed medical implants in January 2024, setting a new benchmark for structural durability in implantable devices.
• restor3d successfully commercialized femoral implants via a cleared additive manufacturing method in January 2024, with mechanical properties that outperform traditional cast implants.
• 3D Systems launched a new multi-material 3D printed denture solution in February 2024, responding to growing demand for personalized dental biomaterials.
• The Korea Institute of Machinery and Materials introduced the world's first 3D bioprinting technology to enhance natural killer (NK) immune cell function, signaling a breakthrough in immunotherapy-linked biomaterials.

Download a sample PDF of this report: https://www.imarcgroup.com/biomaterials-market/requestsample

Key Trends in the Biomaterials Market

• Metallic Biomaterials Leading the Segment: Metallic biomaterials hold the largest share by type, driven by their superior mechanical strength, biocompatibility, and suitability for load-bearing applications such as orthopedic and dental implants. Titanium, stainless steel, and cobalt-chromium alloys are among the most widely adopted. In April 2024, Boston Micro Fabrication received FDA clearance for its UltraThineer material, underscoring the rapid pace of metallic biomaterial innovation.
• Wound Care Emerging as a High-Impact Application: The adoption of biomaterial-based wound dressings is accelerating, as they demonstrably improve healing outcomes for both acute and chronic wounds. In March 2024, scientists at India's Institute of Advanced Study in Science and Technology introduced an eco-friendly wound dressing made from banana fibers under the Department of Science and Technology, reflecting government-backed sustainable biomaterial innovation.
• Tissue Engineering Gaining Regulatory and Commercial Traction: Demand for biomaterial scaffolds that facilitate tissue regeneration is rising sharply. OrganaBio launched NeoPAC placenta and umbilical cord tissues in June 2023 to accelerate regenerative medicine and cell therapy development. The U.S. National Institute of Biomedical Imaging and Bioengineering established the BETA Center in January 2023 specifically to validate and accelerate biomaterials and nanomaterials research.
• North America Maintaining Regional Dominance: North America holds the largest regional market share, supported by a favorable FDA regulatory environment, a growing network of ambulatory surgical centers, and robust R&D infrastructure. As of February 2023, more than 183 ASCs across the United States perform minimally invasive spine surgery, many of which rely directly on advanced biomaterials.
• FDA-Cleared Regenerative Devices Entering Mainstream Use: In October 2023, Dimension Inx announced FDA approval for CMFlex, the first 3D-printed regenerative bone graft product, marking a pivotal milestone for biomaterials in spinal and orthopedic applications.

Growth Factors in the Biomaterials Market

• Rising Prevalence of Musculoskeletal and Cardiovascular Conditions: The increasing global burden of musculoskeletal disorders and cardiovascular diseases is directly expanding demand for implants, stents, pacemakers, and prosthetics, all of which rely heavily on advanced biomaterials. Researchers from Lundquist Institute, Penn State, and UCLA developed novel biomaterials in February 2022 to promote blood vessel formation and address post-stroke immune responses.
• Government and Institutional Investment in Biomaterials R&D: Public institutions are actively funding biomaterials innovation. The National Science Foundation and the National Institute of Standards and Technology in the U.S. continue to provide direct assistance for biomaterials development. India's Department of Science and Technology has co-funded biomaterial initiatives in wound care and surgical tools through institutions like IASST.
• Expanding Applications Across Neurology, Cardiology, and Dental Sectors: Biomaterials now underpin neural implants, brain-machine interfaces, cardiac stents, and precision dental components. The breadth of clinical applications is one of the most powerful structural drivers sustaining market momentum across both developed and emerging economies.
• Polymer Synthesis and Molecular Engineering Breakthroughs: Advancements in protein and peptide engineering, molecular self-assembly, and microfabrication are producing next-generation biomaterials with tailored mechanical, chemical, and biological properties. Researchers from MIT introduced a 3D-printable tissue adhesive in February 2024 with superior tissue adhesion potential for wound care and biomedical device integration.
• Surge in Cosmetic and Reconstructive Surgical Procedures: The growing popularity of plastic and reconstructive surgery is amplifying demand for safe, long-lasting biomaterials in facial implants, breast augmentation, and skin grafting. This trend is particularly pronounced across North America and Asia-Pacific.

Polymeric biomaterial market is growing steadily, driven by rising demand in medical implants, tissue engineering, and advancements in biocompatible material technologies.

Leading Companies Operating in the Global Biomaterials Industry:

• BASF SE
• Berkeley Advanced Biomaterials
• Carpenter Technology Corporation
• Collagen Matrix Inc.
• CoorsTek Inc.
• Corbion N.V.
• Dentsply Sirona
• Evonik Industries AG
• Johnson & Johnson
• Koninklijke DSM N.V.
• Medtronic plc
• Stryker Corporation
• Victrex plc
• Zimmer Biomet

Biomaterials Market Report Segmentation:

Breakup by Type:

• Natural Biomaterial
• Metallic Biomaterial
• Ceramic Biomaterial
• Polymeric Biomaterial

Metallic biomaterial accounts for the largest segment share due to its proven mechanical strength, durability, and suitability for high-load implant applications across orthopedics, dentistry, and cardiovascular devices.

Breakup by Application:

• Neurology
• Cardiology
• Orthopedics
• Wound Care
• Dental
• Plastic Surgery
• Others

Breakup by Region:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

North America maintains a dominant regional position, supported by a mature healthcare infrastructure, active FDA oversight facilitating new material approvals, and a rapidly expanding base of surgical centers performing advanced biomaterial-dependent procedures.

Recent News and Developments in the Biomaterials Market

• February 2024: Researchers from MIT introduced a 3D-printable tissue adhesive demonstrating superior tissue adhesion, with strong potential for enhancing biomedical devices and wound care applications.
• February 2024: 3D Systems launched its new multi-material 3D printed denture offering, targeting growing demand for personalized dental biomaterial solutions.
• January 2024: Evonik introduced the world's first carbon-fiber-reinforced PEEK filament for long-term 3D-printed medical implants, advancing structural performance in implantable biomaterials.
• January 2024: restor3d successfully commercialized femoral implants produced via a previously cleared additive manufacturing method, outperforming the mechanical properties of conventional cast implants.

Note: If you require specific details, data, or insights that are not currently included in the scope of this report, we are happy to accommodate your request. As part of our customization service, we will gather and provide the additional information you need, tailored to your specific requirements. Please let us know your exact needs, and we will ensure the report is updated accordingly to meet your expectations.

About Us:

IMARC Group is a global management consulting firm that helps the world's most ambitious changemakers to create a lasting impact. The company provides a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: [email protected]

Tel No: (D) +91 120 433 0800

United States: +1-201-971-6302